Recombinant Bothrops asper Snake venom metalloproteinase BaP1

Shipped with Ice Packs
In Stock

Description

Introduction

BaP1 is a 22.7-kDa P-I class snake venom metalloproteinase (SVMP) isolated from Bothrops asper venom, a medically significant species in Central America. It induces severe tissue damage, including hemorrhage, myonecrosis, and inflammation, through proteolytic activity and cytokine modulation . To address the limitations of traditional antivenom production (e.g., batch variability, animal immunization), recombinant antibody technologies have been developed to neutralize BaP1. This article focuses on the recombinant single-chain variable fragment (scFvBaP1) engineered against BaP1, its structural and functional properties, and its therapeutic potential.

Structure and Biochemical Properties

BaP1 (Native)

  • Molecular Weight: 22.7 kDa .

  • Active Site: Zinc-dependent, with a consensus sequence H142E143XXH146XXGXXH152 and a Met-turn motif (C164I165M166) .

  • Disulfide Bridges: Three bridges (Cys117-Cys197, Cys159-Cys181, Cys157-Cys164) stabilize the structure .

  • Subdomains: Major (residues 1–152) and minor (residues 153–202) domains linked by a shallow active-site cleft .

Recombinant scFvBaP1

  • Format: Single-chain variable fragment (VH-VL linked by a (G4S)3 peptide) fused to a SUMO tag (13.6 kDa) .

  • Molecular Weight: ~43 kDa (SUMO + scFv) .

  • Expression: Expressed in E. coli C43(DE3) as a cytoplasmic protein .

Neutralization Efficacy

ActivityNeutralization by scFvBaP1Mechanism
Fibrinolysis50% inhibition at 1.25 µM Direct binding to BaP1’s active site, disrupting proteolytic activity .
HemorrhageComplete neutralization Blocks BaP1-mediated endothelial damage and cytokine release .
Muscle NecrosisComplete neutralization Inhibits myotoxic effects via antibody-mediated toxin sequestration .
InflammationReduced cytokine release Suppresses IL-1, TNF-α, and IL-6 production triggered by BaP1 .

Therapeutic Implications

  • Advantages Over Traditional Antivenoms:

    • Consistent batch quality through recombinant production .

    • Reduced immunogenicity compared to horse-derived antivenoms .

    • Targeted neutralization of BaP1, a key pathogenic component .

  • Future Directions:

    • Combination therapies with inhibitors of SVMP-induced cytokine cascades .

    • Engineering scFvBaP1 for improved pharmacokinetics (e.g., half-life extension) .

Research Findings

StudyKey Discovery
Docking Analyses Predicted binding modes of scFvBaP1 to BaP1’s active site .
In Vivo Studies scFvBaP1 neutralizes BaP1-induced tissue damage in animal models .
Structural Biology Crystallographic confirmation of BaP1’s zinc-binding motif .
Immunological Studies BaP1 activates complement system and cytokine networks, exacerbating inflammation .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. For specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchasing method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us for preferential development.
Synonyms
Snake venom metalloproteinase BaP1; SVMP; EC 3.4.24.-; Hemorrhagic metalloproteinase BaP1; Bap-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
192-394
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Bothrops asper (Terciopelo)
Target Protein Sequence
QQRFSPRYI ELAVVADHGI FTKYNSNLNT IRTRVHEMLN TVNGFYRSVD VHAPLANLEV WSKQDLIKVQ KDSSKTLKSF GEWRERDLLP RISHDHAQLL TAVVFDGNTI GRAYTGGMCD PRHSVGVVRD HSKNNLWVAV TMAHELGHNL GIHHDTGSCS CGAKSCIMAS VLSKVLSYEF SDCSQNQYET YLTNHNPQCI LNKP
Uniprot No.

Target Background

Function
Zinc metalloprotease with weak hemorrhagic activity (minimum hemorrhagic dose: 20 µg via intradermal/intramuscular injection in mice). Degrades basement membrane components: collagen IV (all chains), laminin, and nidogen. Rapidly degrades fibrinogen's Aα-chain (FGA), then the Bβ-chain (FGB). Activates the complement system and induces rat neutrophil chemotaxis. Induces edema in mouse footpad and mild myotoxicity.
Protein Families
Venom metalloproteinase (M12B) family, P-I subfamily
Subcellular Location
Secreted.
Tissue Specificity
Expressed by the venom gland.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.